Pathogenetic role ofHelicobacter pylori in duodenal ulcer disease
- 1 April 1991
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 36 (4) , 424-430
- https://doi.org/10.1007/bf01298869
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Persistence ofCampylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritisDigestive Diseases and Sciences, 1987
- Campylobacter pyloridis--a new factor in peptic ulcer disease?Gut, 1986
- Prostaglandin E1 (Misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healingDigestive Diseases and Sciences, 1986
- Overview of misoprostol clinical experienceDigestive Diseases and Sciences, 1986
- A study on the correlation of duodenal‐ulcer healing with campylobacter‐like organismsJournal of Gastroenterology and Hepatology, 1986
- Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.Gut, 1986
- COMPARISON OF TRI-POTASSIUM DI-CITRATO BISMUTHATE TABLETS WITH RANITIDINE IN HEALING AND RELAPSE OF DUODENAL ULCERSThe Lancet, 1985
- IMMUNE RESPONSE TO CAMPYLOBACTER PYLORIDIS IN PATIENTS WITH PEPTIC ULCERATIONThe Lancet, 1985
- PYLORIC CAMPYLOBACTER SEROLOGYThe Lancet, 1984
- DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATEThe Lancet, 1981